Novo Nordisk's stock has dropped to $110 per share, but operational performance remains strong. See why I believe we are at ...

The stock is now heading for an eye-popping annual gain of over ... Learn more here. Market leaders Novo Nordisk and Eli ...

Novo Nordisk (CSE: NOVOb) has been placed on JPMorgan’s Catalyst Watch list, signaling heightened anticipation as the company approaches a pivotal moment in its ...

SAN ANTONIO — Oral semaglutide 25 mg appears to be just as effective in promoting weight loss and other beneficial outcomes ...

(Reuters) - U.S. military veterans face racial and ethnic inequities in access to Novo Nordisk (NYSE: NVO )'s highly in-demand drugs for diabetes and weight loss, according to a review of patient data ...

Any significant move would also need support from Evotec’s other major shareholders — Novo Holdings A/S, the parent company of drugmaker Novo Nordisk A/S ... Bloomberg News reported in June. The stock ...

Rowe Price was the bigger shareholder, with a 10.1% stake, followed by Novo Holdings—the controlling shareholder of Novo ...

Tesla (NASDAQ: TSLA) stock rose 7% after the EV manufacturer’s valuation closed above the $1 trillion mark on Friday, on expectations that CEO Elon Musk's companies will get favorable treatment under ...

Conditions are getting a bit more challenging for the drugmaker.

Brazilian planemaker Embraer's defense unit is planning to open an office in Europe, as sales of its C-390 Millennium ...

ETFs offer a diversified exposure and thus minimize single stock risk but it is still important to delve ... accounts for about 12.88% of total assets, followed by Novo Nordisk A/s (NVO) and Johnson & ...

ALK and ARS Pharmaceuticals sign a deal giving ALK global rights to Neffy nasal spray outside key regions, targeting peak sales of around $400 million in anaphylaxis treatment.